Lin Min, Mao Zhu-Jun
College of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
PeerJ. 2020 Feb 24;8:e8604. doi: 10.7717/peerj.8604. eCollection 2020.
Radix Astragali (Astragalus membranaceus var. mongholicus (Bunge)) and Coptis chinensis (Coptis chinensis var. angustiloba) are two commonly prescribed traditional Chinese herbs for diabetes. Astragalus Polysaccharide (AP) and Berberine (BBR) are active ingredients of these two herbs respectively and they are scientifically proved to have immunomodulatory and anti-inflammatory effects. They are also known for their antidiabetic potential by ameliorating insulin resistance (IR). AP and BBR have shown different advantages in treating diabetes according to previous reports. However, very few studies focus on the combined activities of the two potential antidiabetic ingredients. In this study, we discovered that reactive oxygen species (ROS) accumulated in IR-hepG2 cells and APBBR can decrease ROS level in model group significantly. We conjectured that APBBR can ameliorate IR in hepG2 cells by decreasing ROS level. In order to verify this hypothesis, we obtained phenotype and transcriptome information of IR-HepG2 cells and explore the underlying mechanism of the combination of AP and BBR(APBBR) activity on the relationship between ROS change in IR at whole-transcriptome level, so as to shed new light to efficacy and application of APBBR in treating diabetes.
The IR cell model was established with high-level insulin intervention. Glucose content, HepG2 cell viability as well as ROS level was detected to study the effect of IR-hepG2 cell phenotype. Unbiased genome-wide RNA sequencing was used to investigate alterations in experimental groups. Then, GO and KEGG functional enrichment was performed to explore the function and pathway of target genes. Venn analysis found out the differentially expressed lncRNAs that had close relationship with IR and ROS. Finally, we screened out candidate lncRNAs and these target genes to construct interaction network of differentiated lncRNA-miRNA-mRNA by according to the principle of competitive endogenous RNA (ceRNA).
The biochemical experiments showed that APBBR administration could improve the proliferation activity of IR-HepG2 cells and decrease ROS level in model cells. The GO and KEGG functional enrichment analyses demonstrated several mRNAs remarkably enriched in biological processes and signaling pathways related to ROS production and IR progression. Interaction network suggest that APBBR ameliorates IR in HepG2 cells by regulating the expression of multiple genes and activating relevant signaling pathway to decrease ROS level. Thus, we demonstrated that APBBR ameliorated IR in hepG2 cells via the ROS-dependent pathway.
黄芪(蒙古黄芪)和黄连(三角叶黄连)是两种常用于治疗糖尿病的传统中药。黄芪多糖(AP)和小檗碱(BBR)分别是这两种中药的活性成分,科学证明它们具有免疫调节和抗炎作用。它们还因改善胰岛素抵抗(IR)而具有抗糖尿病潜力。根据先前的报道,AP和BBR在治疗糖尿病方面显示出不同的优势。然而,很少有研究关注这两种潜在抗糖尿病成分的联合活性。在本研究中,我们发现IR - HepG2细胞中活性氧(ROS)积累,而APBBR可显著降低模型组中的ROS水平。我们推测APBBR可通过降低ROS水平改善HepG2细胞中的IR。为了验证这一假设,我们获取了IR - HepG2细胞的表型和转录组信息,并在全转录组水平上探索AP和BBR组合(APBBR)活性对IR中ROS变化关系的潜在机制,从而为APBBR治疗糖尿病的疗效和应用提供新的线索。
通过高浓度胰岛素干预建立IR细胞模型。检测葡萄糖含量、HepG2细胞活力以及ROS水平以研究IR - HepG2细胞表型的影响。使用无偏全基因组RNA测序研究实验组的变化。然后,进行GO和KEGG功能富集以探索靶基因的功能和途径。Venn分析找出与IR和ROS密切相关的差异表达lncRNA。最后,我们根据竞争性内源RNA(ceRNA)原理筛选出候选lncRNA和这些靶基因,构建差异lncRNA - miRNA - mRNA相互作用网络。
生化实验表明,给予APBBR可提高IR - HepG2细胞的增殖活性并降低模型细胞中的ROS水平。GO和KEGG功能富集分析表明,一些mRNA在与ROS产生和IR进展相关的生物学过程和信号通路中显著富集。相互作用网络表明,APBBR通过调节多个基因的表达并激活相关信号通路以降低ROS水平来改善HepG2细胞中的IR。因此,我们证明了APBBR通过ROS依赖性途径改善HepG2细胞中的IR。